Wanshili

Hangzhou Wanshili Silk Sciences and Techniques Co., Ltd. is a prominent Chinese enterprise that has successfully transitioned from a traditional luxury silk manufacturer into a science-led organization focusing on silk protein biotechnology and healthcare. The company specializes in the extraction and application of silk fibroin, a highly biocompatible protein, to develop advanced products for medical devices, regenerative medicine, and high-performance skincare. Its healthcare division produces medical-grade protective equipment, bioactive wound dressings, and antibacterial textiles utilized in clinical and consumer settings. Beyond its commercial portfolio, Wanshili is actively researching silk-based biomaterials for tissue engineering, including artificial nerves and bone scaffolds. Publicly listed on the Shenzhen Stock Exchange, the company represents a unique intersection of material science and modern life science applications.